Roberto Pedro Rosenkranz

Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA.

Part of Laboratory Corp. of America Holdings, Gemini Genomics Plc is a British company that provides clinical genomics services. The company is based in Cambridge, UK. The company was founded by Michael Edward Fitzgerald, Paul James Kelly.

CombiMatrix Corp. engages in the provision of clinical diagnostic services. It offers cytogenomic testing for preimplantation genetic testing, prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. The company was founded in October 1995 and is headquartered in Irvine, CA.

ROXRO Pharma, Inc. develops hospital strength acute pain products. Its products include ROX-888, an intranasal formulation for the treatment of dental and postoperative pain; ROX-828, a non-opioid and non-triptan intranasal product for the treatment of migraine; and SPRIX nasal spray for the short-term management of acute moderate to moderately severe pain that requires analgesia at the opioid level. The company was founded by Michael E Fitzgerald, Roger Whiting and Roberto Pedro Rosenkranz in 1999 and is headquartered in Menlo Park, CA.

Part of Roche Holding AG, Roche Laboratories, Inc. markets and sells pharmaceutical medications. The company is based in Nutley, NJ.

Pherin Pharmaceuticals, Inc. operates as a clinical stage company. It focuses on the development of its proprietary compounds pherines, for the acute treatment of neuropsychiatric and neuroendocrine conditions. The firm’s products include Aloradine, PH10, Salubrin-HF and PH15. The company was founded in 1991 and is headquartered in Los Altos, CA.